Business Context and Reporting Period
Community Healthcare Trust Inc (CHCT) filed a Form 8-K on December 14, 2022, reporting the entry into a material definitive agreement. The filing details a first amendment to the Company's third amended and restated credit agreement with a syndicate of lenders led by Truist Bank.
Key Financial Metrics and Debt Structure
The filing focuses on debt restructuring and liquidity rather than operating performance metrics like revenue or profit, which are not provided in this document.
- New Facility: Established a new seven-year and three-month term loan (A-5 Term Loan) with a principal amount of $150.0 million, maturing March 14, 2030.
- Repayment Activity: Proceeds from the A-5 Term Loan were used to repay a $50 million existing term loan (A-2 Term Loan) and $85 million of outstanding loans under the revolving credit facility.
- Remaining Proceeds: The balance of the $150 million proceeds is expected to fund acquisitions anticipated to close prior to the end of 2022.
- Total Credit Facility Capacity: The amended agreement allows borrowing up to $700.0 million, including an accordion feature for up to an additional $200.0 million.
- Interest Rate Benchmark: The agreement replaces LIBOR with the Secured Overnight Financing Rate (SOFR).
Current Credit Facility Components
| Facility Type | Principal Amount | Maturity Date |
|---|---|---|
| Revolving Facility | $150.0 million | March 19, 2026 (plus 12-month extension option) |
| A-3 Term Loan | $75.0 million | March 29, 2026 |
| A-4 Term Loan | $125.0 million | March 19, 2028 |
| A-5 Term Loan (New) | $150.0 million | March 14, 2030 |
Material Changes Versus Prior Period
The primary material change is the refinancing of the $50 million A-2 Term Loan and the reduction of the revolving credit facility balance by $85 million through the issuance of the new $150 million A-5 Term Loan. Additionally, the benchmark interest rate for all loans under the Credit Agreement has shifted from LIBOR to SOFR.
Guidance, Outlook, and Risks
Management Commentary: The Company intends to enter into additional interest rate swaps to fix the interest rate on the balance of the A-5 Term Loan, following the application of an existing swap to the $50 million portion previously associated with the A-2 Term Loan.
Unusual Items: The filing notes that the summary of the First Amendment is qualified in its entirety by reference to the full text attached as Exhibit 10.1.
Risks: Interest rates on the facilities are floating, based on SOFR plus a margin ranging from 1.25% to 2.30% (or base rate plus 0.25% to 1.30%), depending on the Company's leverage ratio.
Key Facts for Investor Verification
- Verify the specific terms of the interest rate swaps intended to be entered into for the remaining balance of the A-5 Term Loan.
- Confirm the closing status and details of the acquisitions expected to be funded by the remaining loan proceeds before the end of 2022.
- Review the full text of the First Amendment (Exhibit 10.1) for covenants and conditions related to the accordion feature.
- Monitor the Company's leverage ratio to determine the applicable interest rate margins under the new SOFR-based structure.